Diaceutics PLC (AIM:DXRX)

London flag London · Delayed Price · Currency is GBP · Price in GBX
166.50
-1.00 (-0.60%)
At close: Feb 12, 2026
Market Cap142.24M +22.8%
Revenue (ttm)34.40M +31.8%
Net Income-1.52M
EPS-0.02
Shares Out84.92M
PE Ration/a
Forward PE270.16
Dividendn/a
Ex-Dividend Daten/a
Volume682,889
Average Volume195,237
Open167.00
Previous Close167.50
Day's Range165.00 - 169.00
52-Week Range106.00 - 176.25
Beta1.08
RSI60.73
Earnings DateMay 27, 2026

About Diaceutics

Diaceutics PLC, a diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies. The company offers DXRX, a diagnostic commercialization platform for precision medicine that integrates multiple pipelines of diagnostic testing data from a network of laboratories. It also provides DXRX data solutions, including DXRX Signal, which delivers an actionable alert of a testing behavior for making treatment decisions; DXRX Physician Mapping that examines physician testing behavior using... [Read more]

Industry Medical - Diagnostics & Research
Sector Healthcare
Founded 2005
Employees 213
Stock Exchange London Stock Exchange AIM
Ticker Symbol DXRX
Full Company Profile

Financial Performance

In 2024, Diaceutics's revenue was 32.16 million, an increase of 35.69% compared to the previous year's 23.70 million. Losses were -1.70 million, -2.46% less than in 2023.

Financial Statements